Navigation Links
Medicare Announces Expanded Coverage for Anticoagulation Patients, Opening the Door for More Patients to Test PT/INR at Home
Date:3/19/2008

Self-testing could assist physicians in achieving better outcomes for AF,

venous thromboembolism patients

INDIANAPOLIS, March 19 /PRNewswire/ -- Medicare Part B will now cover and pay for meter training, equipment and supplies for all long-term warfarin users who monitor their own PT/INR results at home with portable meters, such as the CoaguChek XS System for Patient Self-Testing. This expansion opens the door to increased patient access to testing, which could lead to better outcomes.

Medicare previously reimbursed these expenses only for patient self- testers who had mechanical heart valves. The new coverage expands to include those on anticoagulant medication with chronic atrial fibrillation and venous thromboembolism.

"The decision to expand coverage to additional disease states allows physicians to manage more of their patients on warfarin therapy through home testing," said Dr. Alan Jacobson, cardiologist, Loma Linda University School of Medicine. "Studies show that more frequent PT/INR testing leads to improved clinical outcomes. The benefits of providing patients with improved access to testing are reductions in strokes, bleeds and deaths."

According to a 2006 international meta-analysis led by Dr. Carl Heneghan and published in the Lancet, patient self-monitoring of oral anticoagulation leads to a significant one-third reduction in death from all causes. The study also showed that thromboembolism was decreased by 55 percent and major hemorrhage was also decreased.(1)

Studies suggest that anticoagulation patients who self-test may experience fewer complications overall than those who do not because self-testing may increase patient time in therapeutic range. A 2001 study published in Z Kardiol reported that over a two-year period, 80 percent of PT/INR values recorded by mechanical heart valve patients who performed self-testing were in target therapeutic range, compared to only 64.9 percent of P
'/>"/>

SOURCE Roche
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Local Medicare Contractors Expand Hypertension Coverage for CardioDynamics BioZ(R) ICG Technology
2. Medicare Contractor Establishes Reimbursement Coding Guidance for Monograms Trofile Assay
3. Oncologists Call For Medicare to Reconsider Anemia Drug Restrictions
4. Lack of Medicare Part D Coverage for All Medically Necessary Prescriptions Endangers Older Americans and Those with Chronic Diseases and Disabilities
5. Genzyme Corporation Selects Diplomat Specialty Pharmacy for 2008 Renagel Medicare Part D Assistance Program
6. Medicare Announces Expanded Coverage for Warfarin Patients Monitoring Clotting Time at Home
7. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
8. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
9. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
10. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
11. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... FRANKLIN, Ohio , Jan. 15, 2014  A novel wearable ... it easy and painless for patients to self-inject prescription drugs ... of disorders, including cancer, blood diseases, autoimmune deficiencies, and genetic ... expected to grow to $220B by 2018, according to analysts.   ...
(Date:1/14/2014)... , Jan. 14, 2014 Dynamic Healthcare Services, Inc. ... today that it acquired Progressive Home Medical Equipment, Inc. ("Progressive") ... 2014. The terms of the acquisition were not disclosed. ... ("DME") company providing a wide range of sleep, mobility, and ...
(Date:1/14/2014)... Inc. , a privately held company pioneering the development ... related neurodegenerative disorders, announced today the relocation of its ... as of January 15, 2014 and expanded lease agreement ... Oligomerix, which is focused on the development ...
Breaking Medicine Technology:Enable Injections Presents A New Class of Injectors for Drug Delivery at PEPTalk, Drug Delivery Partnership Meetings 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 2Dynamic Healthcare Services Completes Progressive Home Medical Equipment of Clarion, PA Investment 3Oligomerix Relocates Corporate Headquarters and Secures Additional Laboratory Space from New York Medical College 2
... New Jersey, October 7, 2010 ... ... ... keyed by longUrl, so we need to grab the first one. for (var r in data.results) { ...
... ZMH and SIX: ZMH) announced today its ... broadcast live over the Internet on Thursday, Oct. 28, 2010, ... quarterly results will be made available at 7:00 a.m. Eastern ... The live audio webcast can be accessed via Zimmer,s Investor ...
Cached Medicine Technology:International Medical News Group Relaunches Internal Medicine News Digital Network and Hospitalist News Digital Network 2International Medical News Group Relaunches Internal Medicine News Digital Network and Hospitalist News Digital Network 3International Medical News Group Relaunches Internal Medicine News Digital Network and Hospitalist News Digital Network 4International Medical News Group Relaunches Internal Medicine News Digital Network and Hospitalist News Digital Network 5International Medical News Group Relaunches Internal Medicine News Digital Network and Hospitalist News Digital Network 6International Medical News Group Relaunches Internal Medicine News Digital Network and Hospitalist News Digital Network 7International Medical News Group Relaunches Internal Medicine News Digital Network and Hospitalist News Digital Network 8Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2010 Results 2
(Date:4/18/2014)... being prepped to enter the battle against infectious ... diseases in remote areas, thanks in part to ... the International Space Station on the behavior of ... capillary flow to diagnose infectious diseases such as ... researcher at Northwestern University in Evanston, Ill., had ...
(Date:4/18/2014)... researchers have been awarded two-year grants for their work ... month. Of the 110 initial submissions to the new ... only four projects were funded, three of which are ... M.D., Ph.D.; G. William Wong, Ph.D.; and Elias Zambidis, ... oncology, will use his $500,000 proof of principle grant ...
(Date:4/18/2014)... Two Simon Fraser University psychologists have made a ... treatment of attention-deficit disorders. , This discovery opens ... may hinder or suppress a specific brain activity ... prevent distraction. , The Journal of Neuroscience ... discovery by John McDonald, an associate professor of ...
(Date:4/18/2014)... lead to potential new treatments for breaking the cycle ... Fibrosis, or scarring, is a hallmark of the disease, ... lead to serious organ damage and, in some cases, ... on findings made by Swati Bhattacharyya, PhD, research assistant ... specific protein plays in promoting fibrosis. , "Our ...
(Date:4/17/2014)... variant specifically associated with the risk of a ... cent of all breast cancer cases. , The ... called invasive lobular carcinoma, gives researchers important clues ... of breast cancer, which can be missed through ... the journal PloS Genetics , was co-led ...
Breaking Medicine News(10 mins):Health News:Space-tested fluid flow concept advances infectious disease diagnoses 2Health News:Space-tested fluid flow concept advances infectious disease diagnoses 3Health News:Scientists discover brain's anti-distraction system 2Health News:New clues on tissue scarring in scleroderma 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 2Health News:First genetic link discovered to difficult-to-diagnose breast cancer sub-type 3
... MDTH ) announced that its senior management will give ... January,7 - 10, 2008 at the Westin St. Francis ... give its presentation on Thursday,January 10, 2008 at 10:00 ... the Internet via MedCath,s website (http://www.medcath.com ) and,will ...
... Show with, Fashions by Chloe Dao, Presented by Rachel Hunter, Benefiting Dress ... ... Culminating a year of,empowering women to ,find their slim, and supporting the ... with the Style Your Slim(SM) Fashion Show in Los Angeles, CA, on,January 8th. ...
... SOUTH WINDSOR, Conn., Jan. 2 Gerber,Scientific, Inc. (NYSE: ... announced that Marc T. Giles, President and Chief Executive,Officer, ... Conference,being held in New York on Tuesday, January 8, ... of the presentation will be available on the home ...
... of Aetna, Inc., LOVELAND, Colo., Jan. 2 ... that Ms. Louise McCormick has joined the,company,s Board ... "We pride ourselves on our commitment to excellence ... quality, independent Directors,is critical to this effort," said ...
... finds whites are prescribed opioids more often than blacks, Hispanics ... in an emergency room in significant pain, you are less ... if you are not white, new research shows. , The ... that minorities don,t get effective pain treatment in the ER ...
... benefits outweigh its risks , , WEDNESDAY, Jan. 2 (HealthDay ... cause high blood pressure in patients with kidney cancer, ... of a study published last month that found the ... failure among patients with stomach cancer. , "Patients taking ...
Cached Medicine News:Health News:Slim-Fast Celebrates Weight Loss by Hosting Style Your Slim(SM) Fashion Show Featuring Real Women 2Health News:Slim-Fast Celebrates Weight Loss by Hosting Style Your Slim(SM) Fashion Show Featuring Real Women 3Health News:Slim-Fast Celebrates Weight Loss by Hosting Style Your Slim(SM) Fashion Show Featuring Real Women 4Health News:Gerber Scientific to Present at 10th Annual Needham Growth Stock Conference 2Health News:Louise McCormick Joins Heska's Board of Directors 2Health News:Louise McCormick Joins Heska's Board of Directors 3Health News:Minorities Less Likely to Get Powerful Painkillers in ER 2Health News:Minorities Less Likely to Get Powerful Painkillers in ER 3Health News:New Cancer Drug Boosts Blood Pressure 2Health News:New Cancer Drug Boosts Blood Pressure 3
Intended for the quantitative in vitro enzymatic determination of JDL-Cholesterol in human serum or plasma. Two point reaction. Wavelength: 600 nm. Linearity: 1 to 150 mg/dL (0.03 mmol/L to 3.89 mmol...
Ready to use liquid single reagent for automated chemistry analyzers. Linearity to 1000 mmol/L...
The new ProteomeX Workstation enables the rapid set up, execution and analysis of multidimensional LC/MS methods, providing you with the best possible technique to characterize your complex proteomic...
Intended for the quantitative determination of triglycerides in serum or plasma. Reaction: endpoint. Wavelength: 520 nm. Linearity: 1000 mg/dL (11.3 mmol/L). Single vial, dry powder reagent....
Medicine Products: